Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04559893 · ClinicalTrials.gov registry record · NA
Collaboration Leading to Addiction Treatment and Recovery From Other Stresses
A NA study, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 729
- Enrollment target
NCT04559893 is a NA study that has completed, run by RAND. The registered enrollment target is 729 participants.
The verdict
NCT04559893, a NA study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 729 participants
- Enrollment target
Study Summary
Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO) is a five-year project that tests whether delivering care using a collaborative model helps patients with both opioid use disorders and mental health disorders.
Interventions
- BEHAVIORAL Collaborative Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 729 participants |
| Start Date | 2021-01-08 |
| Est. Completion | 2024-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04559893
The ClinicalTrials.gov registry entry for NCT04559893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 729 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collaborative Care is the first listed.
NCT04559893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04559893 about?
NCT04559893 is a clinical study titled "Collaboration Leading to Addiction Treatment and Recovery From Other Stresses". Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO) is a five-year project that tests whether delivering care using a collaborative model helps patients with both opioid use disorders and mental health disorders.
What is the current status of trial NCT04559893?
This trial is currently completed. It is a NA study. The enrollment target is 729 participants. The study started on 2021-01-08. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT04559893?
The interventions under investigation include: Collaborative Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04559893?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.